<VariationArchive VariationID="1459603" VariationName="NM_002351.5(SH2D1A):c.245dup (p.Asn82fs)" VariationType="Duplication" Accession="VCV001459603" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1484791" VariationID="1459603">
      <GeneList>
        <Gene Symbol="SH2D1A" FullName="SH2 domain containing 1A" GeneID="4068" HGNC_ID="HGNC:10820" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="124346563" stop="124373160" display_start="124346563" display_stop="124373160" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="123480131" stop="123507009" display_start="123480131" display_stop="123507009" Strand="+" />
          </Location>
          <OMIM>300490</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SH2D1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SH2D1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_002351.5(SH2D1A):c.245dup (p.Asn82fs)</Name>
      <CanonicalSPDI>NC_000023.11:124370213:AAAAAA:AAAAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="124370213" stop="124370214" display_start="124370213" display_stop="124370214" variantLength="1" positionVCF="124370213" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="123504063" stop="123504064" display_start="123504063" display_stop="123504064" variantLength="1" positionVCF="123504063" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>N82fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.123504069dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.123504069dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.124370219dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.124370219dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007464.1" sequenceAccession="NG_007464" sequenceVersion="1" change="g.28920dup">
            <Expression>NG_007464.1:g.28920dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033796.2" sequenceAccession="NG_033796" sequenceVersion="2" change="g.414660dup">
            <Expression>NG_033796.2:g.414660dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114937.3" sequenceAccession="NM_001114937" sequenceVersion="3" change="c.245dup">
            <Expression>NM_001114937.3:c.245dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001108409.1" sequenceAccession="NP_001108409" sequenceVersion="1" change="p.Asn82fs">
            <Expression>NP_001108409.1:p.Asn82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002351.5" sequenceAccession="NM_002351" sequenceVersion="5" change="c.245dup" MANESelect="true">
            <Expression>NM_002351.5:c.245dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002342.1" sequenceAccession="NP_002342" sequenceVersion="1" change="p.Asn82fs">
            <Expression>NP_002342.1:p.Asn82fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_106" sequenceAccession="LRG_106">
            <Expression>LRG_106:g.28920dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_782" sequenceAccession="LRG_782">
            <Expression>LRG_782:g.414660dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2147534047" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002351.5(SH2D1A):c.245dup (p.Asn82fs) AND X-linked lymphoproliferative disease due to SH2D1A deficiency" Accession="RCV001963121" Version="5">
        <ClassifiedConditionList TraitSetID="3039">
          <ClassifiedCondition DB="MedGen" ID="C5399825">X-linked lymphoproliferative disease due to SH2D1A deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20632414</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28816794</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3039" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5424" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Purtilo syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EBV infection severe susceptibility to</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epstein Barr virus infection familial fatal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duncan's syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Duncan disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to SH2D1A deficiency</ElementValue>
                <XRef ID="MONDO:0024551" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 1, X-linked</ElementValue>
                <XRef ID="Lymphoproliferative+syndrome+X-linked+1/4379" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY 5</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMMUNODEFICIENCY, X-LINKED PROGRESSIVE COMBINED VARIABLE</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">INFECTIOUS MONONUCLEOSIS, SEVERE, SUSCEPTIBILITY TO</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LYP</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLP</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EBVS</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD5</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">XLP1</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLPD</ElementValue>
                <XRef Type="MIM" ID="308240" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7906" />
                <XRef ID="7906" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538931" DB="Orphanet" />
              <XRef ID="C5399825" DB="MedGen" />
              <XRef ID="MONDO:0024551" DB="MONDO" />
              <XRef Type="MIM" ID="308240" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4257518" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4978529|MedGen:C1868674" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002242037" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28816794</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20632414</ID>
          </Citation>
          <Comment>This variant disrupts a region of the SH2D1A protein in which other variant(s) (p.Gly93Asp) have been observed in individuals with SH2D1A-related conditions (PMID: 28816794). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1459603). This variant is also known as g.23917insA. This premature translational stop signal has been observed in individual(s) with X-linked lymphoproliferative syndrome (PMID: 20632414; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asn82Lysfs*22) in the SH2D1A gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 47 amino acid(s) of the SH2D1A protein. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SH2D1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.123504063_123504064insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868674" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4257518" TraitType="Disease" MappingType="XRef" MappingValue="C1868674" MappingRef="MedGen">
        <MedGen CUI="C5399825" Name="X-linked lymphoproliferative disease due to SH2D1A deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

